Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jul;35(7):6831-8.
doi: 10.1007/s13277-014-1939-4. Epub 2014 Apr 13.

Obesity and the risk of cholangiocarcinoma: a meta-analysis

Affiliations
Meta-Analysis

Obesity and the risk of cholangiocarcinoma: a meta-analysis

Jun-Shan Li et al. Tumour Biol. 2014 Jul.

Abstract

A number of studies have shown that obesity is implicated in the susceptibility to several cancers. However, the association between obesity and cholangiocarcinoma remains unclear. This meta-analysis aimed to quantitatively assess the association between overweight or obesity and the incidence of cholangiocarcinoma. A literature search was performed for cohort and case-control studies published from 1996 to 2013 using PubMed, Cochrane, and EMBASE databases. Studies were included if they reported odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) of cholangiocarcinoma with respect to obesity or overweight. Normal weight, overweight, and obesity were defined when the body mass index (BMI) was 18.5-24.9, 25-29.9, and ≥ 30 kg/m(2), respectively. Excess body weight was defined as BMI ≥ 25 kg/m(2). Ten studies met the inclusion criteria, which included five cohort and five case-control studies. Compared with normal weight, being overweight (pooled OR 1.30, 95 % CI 1.13-1.49), obesity (pooled OR 1.52, 95 % CI 1.13-1.89), and excess body weight (pooled OR 1.37, 95 %CI 1.22-1.55) were significantly associated with cholangiocarcinoma. The funnel plot revealed no evidence for publication bias. Obesity is associated with the increased risk of cholangiocarcinoma, which needs to be confirmed by long-term cohort studies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Cancer Prev. 2011 Nov;20(6):556 - PubMed
    1. Int J Cancer. 2007 Feb 1;120(3):638-41 - PubMed
    1. Carcinogenesis. 2009 Apr;30(4):566-74 - PubMed
    1. Cancer Causes Control. 2004 Feb;15(1):35-43 - PubMed
    1. Chemosphere. 2009 Aug;76(6):841-6 - PubMed

Publication types

LinkOut - more resources